Hongzhen Bai

9PUBLICATIONS
14CO-AUTHORS
Medical devicesGlycoconjugatesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 24, 2025
Biomimetic rhCOL17-P334 Conjugate for Enhanced Wound Healing.

Yijie Lou, Chunyan Dai, Shuting Feng

|Feb 20, 2025
Cyclodextrin-Initiated N-Carboxyanhydride Polymerization for the Design of Stereostructural Dobby Polypeptides with Jellyfish-Type Architecture.

Guoqiao Xu, Guping Tang, Hongzhen Bai

|Oct 29, 2024
A Hybrid Alloying Nanozyme-Glutathione Inhibitor Co-Delivery System Initiates a Dual-Disruption on Cancer Redox Homeostasis.

Jue Hou, Hanxiao Bao, Yu Wang

|Nov 09, 2021
Chitosan-derived nanoparticles impede signal transduction in T790M lung cancer therapy.

Guojun Huang, Qi Chen, Jiawei Hu

|Feb 04, 2021
Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment.

Hongzhen Bai, Jianwei Wang, Chi Uyen Phan

Pageof 2